首页> 美国卫生研究院文献>other >Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells In Vitro
【2h】

Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells In Vitro

机译:色素上皮衍生因子抑制人子宫内膜植入物的生长的实验研究及卵巢异位内膜间质细胞的体外

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Angiogenesis is a prerequisite for the formation and development of endometriosis. Pigment epithelium derived factor (PEDF) is a natural inhibitor of angiogenesis. We previously demonstrated a reduction of PEDF in the peritoneal fluid, serum and endometriotic lesions from women with endometriosis compared with women without endometriosis. Here, we aim to investigate the inhibitory effect of PEDF on human endometriotic cells in vivo and in vitro. We found that PEDF markedly inhibited the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro by up-regulating PEDF expression and down-regulating vascular endothelial growth factor (VEGF) expression. Moreover, apoptotic index was significantly increased in endometriotic lesions in vivo and endometriotic stromal cells in vitro when treated with PEDF. In mice treated with PEDF, decreased microvessel density labeled by Von Willebrand factor but not by α-Smooth Muscle Actin was observed in endometriotic lesions. And it showed no increase in PEDF expression of the ovary and uterus tissues. These findings suggest that PEDF gene therapy may be a new treatment for endometriosis.
机译:血管生成是子宫内膜异位症形成和发展的先决条件。色素上皮衍生因子(PEDF)是天然的血管生成抑制剂。我们先前证明,与没有子宫内膜异位的女性相比,患有子宫内膜异位的女性的腹膜液,血清和子宫内膜异位病变中的PEDF减少。在这里,我们旨在研究PEDF在体内和体外对人子宫内膜异位细胞的抑制作用。我们发现,PEDF通过上调PEDF的表达和下调血管内皮生长因子(VEGF)的表达,明显抑制裸鼠和子宫内膜异位基质细胞在人子宫内膜植入物中的生长。此外,当用PEDF处理时,体内子宫内膜异位病变和体外子宫内膜异位基质细胞的凋亡指数显着增加。在用PEDF处理的小鼠中,在子宫内膜异位病变中观察到由Von Willebrand因子标记但未由α-平滑肌肌动蛋白标记的微血管密度降低。并且它没有显示PEDF在卵巢和子宫组织中的表达增加。这些发现表明,PEDF基因疗法可能是子宫内膜异位症的一种新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号